Neuroone Medical Technologies (NMTC) Cash from Investing Activities (2017 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Cash from Investing Activities came in at -$38516.0 in Q1 2026, down 1114.63% YoY from $3796.1 in Q1 2025, and up 5.49% on a QoQ basis from -$40754.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 10 years of Cash from Investing Activities data on file, last reported at -$38516.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 1114.63% year-over-year to -$38516.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$133425.0 (down 68.27% YoY) and the FY2025 annual result came in at -$81742.0, up 31.99% from the prior year.
- Cash from Investing Activities advanced to -$38516.0 in Q1 2026, from -$40754.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1.8 million in Q1 2023 to a low of -$3.0 million in Q3 2022.
- A 5-year average of -$47912.9 and a median of -$36905.0 in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 8546.56% — and 2023, when it surged 2054.91%.
- Tracing NMTC's Cash from Investing Activities over 5 years: stood at $15069.0 in 2022, then plunged by 346.41% to -$37131.0 in 2023, then surged by 34.24% to -$24416.0 in 2024, then tumbled by 66.92% to -$40754.0 in 2025, then advanced by 5.49% to -$38516.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$38516.0 (Q1 2026), -$40754.0 (Q4 2025), and -$10607.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Neuroone Medical Technologies | 19.38 Mn | 17.33 Mn | 1.18 Mn | -19,659.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19,659.00 |
| Jun 30, 2026 | -19,659.00 |
| Mar 31, 2026 | -38,516.00 |
| Mar 31, 2026 | -38,516.00 |
| Dec 31, 2025 | -40,754.00 |
| Dec 31, 2025 | -40,754.00 |
| Sep 30, 2025 | -10,607.00 |
| Sep 30, 2025 | -10,607.00 |
| Jun 30, 2025 | -43,548.00 |
| Jun 30, 2025 | -43,548.00 |
| Mar 31, 2025 | -3,171.00 |
| Mar 31, 2025 | -3,171.00 |
| Dec 31, 2024 | -24,416.00 |
| Dec 31, 2024 | -24,416.00 |
| Sep 30, 2024 | -36,905.00 |
| Sep 30, 2024 | -36,905.00 |
| Jun 30, 2024 | -14,801.00 |
| Jun 30, 2024 | -14,801.00 |
| Mar 31, 2024 | -31,360.00 |
| Mar 31, 2024 | -31,360.00 |